Location History:
- Danville, CA (US) (2009 - 2013)
- San Ramon, CA (US) (2014)
Company Filing History:
1 out of 192 
1 out of 780 
1 out of 22 Years Active: 2009-2014
Title: The Innovative Contributions of Fang Jin
Introduction
Fang Jin is a notable inventor based in Danville, CA (US), recognized for his significant contributions to the field of biotechnology. With a total of 3 patents, he has made strides in developing methods and compositions that enhance the production of recombinant proteins and therapeutic viruses.
Latest Patents
Fang Jin's latest patents include innovative methods for producing recombinant proteins in HBX-expressing mammalian cells. This method allows for the growth of mammalian host cells, such as HKB11, CHO, BHK21, C2C12, and HEK293, in non-adherent suspension culture. The conditions are optimized to ensure that HBx, exogenous XBP1s, and the heterologous protein are effectively expressed by the mammalian cells. Additionally, he has developed a patent related to the generation of replication-competent viruses for therapeutic use. These viruses are designed to express proteins that can be beneficial in treating various diseases.
Career Highlights
Fang Jin has worked with prominent companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Bayer Healthcare LLC. His experience in these organizations has contributed to his expertise in biotechnology and innovation.
Collaborations
Fang has collaborated with notable professionals in his field, including Terry Hermiston and Peter Kretschmer. These partnerships have likely enhanced his research and development efforts.
Conclusion
Fang Jin's work exemplifies the impact of innovative thinking in biotechnology. His patents and collaborations reflect a commitment to advancing therapeutic solutions and improving protein production methods.